By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
FDA Conducts Major Global Operation To Protect Consumers From Potentially Dangerous Prescription Drugs Sold Online 9/25/2017 12:30:46 PM
Biophytis Filed IND Application For Approval By FDA Of SARA-INT Phase IIb Study Of Sarconeos In Sarcopenia 9/25/2017 11:47:50 AM
Novan Conducts Guidance Meeting With FDA On SB204 Development Program 9/25/2017 11:35:32 AM
Janssen R&D Submits New Drug Application To FDA For The First Darunavir-Based Single Tablet Regimen For The Treatment Of HIV-1 9/25/2017 10:54:31 AM
Bracco Diagnostics Receives U.S. FDA Approval For TAGITOL V (Barium Sulfate) Oral Suspension 9/25/2017 10:49:46 AM
Allergan (AGN) Receives Refusal To File Letter From FDA For Vraylar (Cariprazine) Supplemental New Drug Application (Snda) For The Treatment Of Negative Symptoms In Schizophrenia 9/25/2017 9:39:54 AM
ProMetic Life Sci (PFSCF.PK) Receives FDA Clearance Of Its IND To Initiate Pivotal PBI-4050 Phase II/III Trial In Patients With Idiopathic Pulmonary Fibrosis 9/25/2017 9:38:16 AM
Ocugen, Inc. Announces FDA Acceptance Of Investigational New Drug Application For OCU310 (Brimonidine/Steroid Combination Therapy) And Initiates Proof Of Concept Study For Treatment Of Dry Eye Disease 9/25/2017 9:34:33 AM
Aradigm (ARDM) Announces FDA Acceptance Of NDA For Linhaliq With Priority Review Status 9/25/2017 9:24:25 AM
BioPharma Services Completes Its 1st Year Of A 5 Year Phase 1 Program With The U.S. FDA 9/25/2017 9:07:21 AM